FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210376742> ?p ?o ?g. }

• W3210376742 abstract "Cisplatin (CDDP) based chemotherapy is widely used as the first-line strategy in treating non-small cell lung cancer (NSCLC), especially lung squamous cell carcinoma (LUSC). However, secondary cisplatin resistance majorly undermines the cisplatin efficacy leading to a worse prognosis. In this respect, we have identified the role of the DLX6-AS1/miR-181a-5p/miR-382-5p/CELF1 axis in regulating cisplatin resistance of LUSC. qRT-PCR and Western blot analysis were applied to detect gene expression. Transwell assay was used to evaluate the migration and invasion ability of LUSC cells. CCK-8 assay was used to investigate the IC50 of LUSC cells. Flow cytometry was used to test cell apoptosis rate. RNA pull-down and Dual luciferase reporter gene assay were performed to evaluate the crosstalk. DLX6-AS1 was aberrantly high expressed in LUSC tissues and cell lines, and negatively correlated with miR-181a-5p and miR-382-5p expression. DLX6-AS1 expression was enhanced by H3K4me1 in cisplatin resistant LUSC cells. Besides, DLX6-AS1 knockdown led to impaired IC50 of cisplatin resistant LUSC cells. Furthermore, DLX6-AS1 interacted with miR-181a-5p and miR-382-5p to regulate CELF1 expression and thereby mediated the cisplatin sensitivity of cisplatin resistant LUSC cells. DLX6-AS1 induced by H3K4me1 played an important role in promoting secondary cisplatin resistance of LUSC through regulating the miR-181a-5p/miR-382-5p/CELF1 axis. Therefore, targeting DLX6-AS1 might be a novel way of reversing secondary cisplatin resistance in LUSC." @default.
• W3210376742 created "2021-11-08" @default.
• W3210376742 creator A5012051639 @default.
• W3210376742 creator A5018805442 @default.
• W3210376742 creator A5025453964 @default.
• W3210376742 creator A5056595025 @default.
• W3210376742 creator A5057715969 @default.
• W3210376742 date "2021-10-25" @default.
• W3210376742 modified "2023-10-02" @default.
• W3210376742 title "DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis" @default.
• W3210376742 cites W2009858080 @default.
• W3210376742 cites W2051829948 @default.
• W3210376742 cites W2409586275 @default.
• W3210376742 cites W2752733790 @default.
• W3210376742 cites W2752998158 @default.
• W3210376742 cites W2765744146 @default.
• W3210376742 cites W2886819263 @default.
• W3210376742 cites W2890554786 @default.
• W3210376742 cites W2895958618 @default.
• W3210376742 cites W2899769366 @default.
• W3210376742 cites W2915083816 @default.
• W3210376742 cites W2933063538 @default.
• W3210376742 cites W2942910851 @default.
• W3210376742 cites W2949571420 @default.
• W3210376742 cites W2952542100 @default.
• W3210376742 cites W2965891425 @default.
• W3210376742 cites W2970334743 @default.
• W3210376742 cites W2971126595 @default.
• W3210376742 cites W2981200786 @default.
• W3210376742 cites W2987111723 @default.
• W3210376742 cites W3007064031 @default.
• W3210376742 cites W3008526513 @default.
• W3210376742 cites W3016075093 @default.
• W3210376742 cites W3022440317 @default.
• W3210376742 cites W3025087299 @default.
• W3210376742 cites W3027373572 @default.
• W3210376742 cites W3032967666 @default.
• W3210376742 cites W3034980736 @default.
• W3210376742 cites W3036014037 @default.
• W3210376742 cites W3036598403 @default.
• W3210376742 cites W3037080383 @default.
• W3210376742 cites W3037718479 @default.
• W3210376742 cites W3037746870 @default.
• W3210376742 cites W3043165428 @default.
• W3210376742 cites W3043361538 @default.
• W3210376742 cites W3044809608 @default.
• W3210376742 cites W3083842960 @default.
• W3210376742 cites W3084251573 @default.
• W3210376742 cites W3088729514 @default.
• W3210376742 cites W3092045953 @default.
• W3210376742 cites W3112781258 @default.
• W3210376742 cites W3113363746 @default.
• W3210376742 cites W3128212391 @default.
• W3210376742 doi "https://doi.org/10.1038/s41598-021-99555-8" @default.
• W3210376742 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8546124" @default.
• W3210376742 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34697393" @default.
• W3210376742 hasPublicationYear "2021" @default.
• W3210376742 type Work @default.
• W3210376742 sameAs 3210376742 @default.
• W3210376742 citedByCount "12" @default.
• W3210376742 countsByYear W32103767422022 @default.
• W3210376742 countsByYear W32103767422023 @default.
• W3210376742 crossrefType "journal-article" @default.
• W3210376742 hasAuthorship W3210376742A5012051639 @default.
• W3210376742 hasAuthorship W3210376742A5018805442 @default.
• W3210376742 hasAuthorship W3210376742A5025453964 @default.
• W3210376742 hasAuthorship W3210376742A5056595025 @default.
• W3210376742 hasAuthorship W3210376742A5057715969 @default.
• W3210376742 hasBestOaLocation W32103767421 @default.
• W3210376742 hasConcept C126322002 @default.
• W3210376742 hasConcept C153911025 @default.
• W3210376742 hasConcept C173396325 @default.
• W3210376742 hasConcept C185592680 @default.
• W3210376742 hasConcept C190283241 @default.
• W3210376742 hasConcept C2776694085 @default.
• W3210376742 hasConcept C2778239845 @default.
• W3210376742 hasConcept C502942594 @default.
• W3210376742 hasConcept C54355233 @default.
• W3210376742 hasConcept C553184892 @default.
• W3210376742 hasConcept C55493867 @default.
• W3210376742 hasConcept C71924100 @default.
• W3210376742 hasConcept C81885089 @default.
• W3210376742 hasConcept C86803240 @default.
• W3210376742 hasConceptScore W3210376742C126322002 @default.
• W3210376742 hasConceptScore W3210376742C153911025 @default.
• W3210376742 hasConceptScore W3210376742C173396325 @default.
• W3210376742 hasConceptScore W3210376742C185592680 @default.
• W3210376742 hasConceptScore W3210376742C190283241 @default.
• W3210376742 hasConceptScore W3210376742C2776694085 @default.
• W3210376742 hasConceptScore W3210376742C2778239845 @default.
• W3210376742 hasConceptScore W3210376742C502942594 @default.
• W3210376742 hasConceptScore W3210376742C54355233 @default.
• W3210376742 hasConceptScore W3210376742C553184892 @default.
• W3210376742 hasConceptScore W3210376742C55493867 @default.
• W3210376742 hasConceptScore W3210376742C71924100 @default.
• W3210376742 hasConceptScore W3210376742C81885089 @default.
• W3210376742 hasConceptScore W3210376742C86803240 @default.
• W3210376742 hasFunder F4320324173 @default.
• W3210376742 hasIssue "1" @default.
• W3210376742 hasLocation W32103767421 @default.

• next